<DOC>
	<DOCNO>NCT02220127</DOCNO>
	<brief_summary>Gamma Knife Radiosurgery ( GKR ) well-established treatment modality brain metastasis ( Chiou 2013 ; Salvetti , Nagaraja et al . 2013 ) . Large multicentre series publish patient single multiple cerebral metastasis , treat GKR period 30 year ( Karlsson , Hanssens et al . 2009 ) . Multiple institution report consistently high local tumour control rate 80 % -90 % follow GKR ( Chang , Lee et al . 2000 ; Da Silva , Nagayama et al . 2009 ; Salvetti , Nagaraja et al . 2013 ) . There controversy use GKR and/or Whole Brain Radiotherapy ( WBRT ) patient multiple metastasis . WBRT provide low rate distant recurrence , whereas GKR achieve good local control treat lesion without deleterious side effect radiotherapy ( Lippitz , Lindquist et al . 2014 ) . This discussion mainly focus risk distant recurrence , low WBRT give . There evidence show Radiosurgery ( RS ) base high contrast/resolution stereotactic MRI decrease incidence lengthens time distant recurrence ( Hanssens , Karlsson et al . 2011 ) . As result , current tendency treat lesion visible high contrast/resolution image day Gamma Knife ; follow regular MRI follow ups subsequent GKR distant recurrence order avoid/delay WBRT . It estimate half distant recurrence grow tumour cell already brain ( micrometastases ) radiosurgery deliver , much study optimal prescription radiation delivery method lesion . There controversy collimator use treat micro-metastases ( BmM ) . These lesion either treat 4mm collimator isodose 40 % 90 % , 8mm collimator isodose 90 % . The 8 mm collimator think offer well Local Control Rate ( LCR ) advantage faster deliver treatment , 4 mm collimator consider safer , give steep dose fall-off . It aim study find 4 mm 8 mm collimator achieve high LCR less complication . A large number lesion randomise either 4 8 mm collimator patient follow evaluate clinical efficacy .</brief_summary>
	<brief_title>RCT 4mm vs. 8mm Collimator GKR Brain Micrometastases</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Micrometastasis</mesh_term>
	<criteria>Adult patient brain metastasis primary tumour receive GKR . All intracranial micrometastases include lesion locate cerebral hemisphere , thalamus , basal ganglion cerebellum exclude lesion locate brain stem level superior colliculi . Target volume &lt; 0.14 cc3 maximum diameter &lt; 7 mm . The subject consent participate study . Inability consent Younger 18 year age . Lesions brainstem ( level superior colliculi ) well treat 4 mm collimator exclude study . Patients 25 brain lesion suitable randomisation exclude study . Comorbidity previous treatment surgery , chemotherapy WBRT consider exclusion criterion . Pregnancy context brain metastasis contraindication GKR , therefore consider exclusion criterion trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Brain</keyword>
	<keyword>Neoplasm Micrometastasis</keyword>
	<keyword>Gamma Knife Radiosurgery</keyword>
</DOC>